Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation

Published:2022-02 Issue:2 Volume:10 Page:e278-e287
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Su Shu,Wong William CW,Zou Zhuoru,Cheng Dan Dan,Ong Jason J,Chan Polin,Ji Fanpu,Yuen Man-Fung,Zhuang Guihua,Seto Wai-Kay,Zhang Lei

Funder

National Health and Medical Research Council

National Natural Science Foundation of China

Xi’an Jiaotong University

University of Hong Kong

Publisher

Elsevier BV

Subject

General Medicine

Reference38 articles.

1. The hepatitis B epidemic in China should receive more attention;Chen;Lancet,2018

2. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China;Cui;Emerg Infect Dis,2017

3. Global health sector strategy on viral hepatitis 2016–2021,2016

4. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study;Razavi-Shearer;Lancet Gastroenterol Hepatol,2018

5. Strategy vaccination against Hepatitis B in China;Liao;Hum Vaccin Immunother,2015

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends and multi-model prediction of hepatitis B incidence in Xiamen;Infectious Disease Modelling;2024-12

2. Automated data collection tool for real-world cohort studies of chronic hepatitis B: Leveraging OCR and NLP technologies for improved efficiency;New Microbes and New Infections;2024-12

3. Effects and Costs of Hepatitis C Virus Elimination for the Whole Population in China: A Modelling Study;PharmacoEconomics;2024-09-02

4. Economic evaluation of hepatocellular carcinoma surveillance in chronic hepatitis B patients with virological remission;BMC Public Health;2024-08-13

5. S100A8/A9-activated IFNγ+ NK cells trigger β-cell necroptosis in hepatitis B virus-associated liver cirrhosis;Cellular and Molecular Life Sciences;2024-08-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3